Institutional investors purchased a net $4.9 million shares of CHTP during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 38.38% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Individual stakeholders | 25.91% |
| Other institutional | 23.43% |
| Mutual fund holders | 14.96% |